Page 2 - Inhalation Sciences News Today

In a renewed partnership Karolinska Institutet in Stockholm will help validate ISABs new XposeALI® MP tool, including using it to test a Mars dust surrogate for the European Space Agency... | October 12, 2021

Published: May 13, 2021 By Alex Keown Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by m...

April 20, 2021) Inhalation Sciences (ISAB) has signed an agreement with prestigious lead generation company Cience and with Coelus Bio, a boutique CRO consulting firm specialized in inhalation drug development, to generate new leads and sales in the US. It is part of the marketing activities aimed at growing ISABs sales and presence in the US, a strategic goal for 2021, and becoming a clear market leader in its niche. With strengthened sales in 2020 ISAB identified expanding its marketing and ...

Inhalation Sciences Sweden : news roundup spring 2021 03/03/2021 | 05:04am EDT Send by mail : Message : AQUILON PHARMA PURCHASES PRECISEINHALE FOR INNOVATIVE ASTHMA AND COPD RESEARCH Aquilon Pharma, based in Belgium, has purchased ISABs high-precision R&D system PreciseInhale®, plus its Nose-Only and Intratracheal Exposure Modules, to help drive forward their innovative portfolio of new formulations to improve the efficacy of inhaled drugs for asthma and COPD (Chronic Pulmonary Obstru...

Toronto, ON (PRWEB) March 03, 2021 -- Inhaled studies are often perceived as technically challenging, and varied regulations around the world add another

Were Not Counting On Inhalation Sciences Sweden (NGM:ISAB) To Sustain Its Statutory Profitability By December 29, 2020 Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability suggests a business is sustainable. That said, the current statutory profit is not always a good guide to a companys underlying profitability. In this article, well look at how useful this years statutory profit is, when analysing Inhalation Sciences Sweden ...